You are here

Treatment for neurodegenerative diseases

Invention Number: 
13_2767
Multiple Sclerosis, Motor Neuron and Huntington's Disease could all be treated much more efficiently in the future. A discovery to promote neuronal regeneration.

The Discovery

UNSW researchers have identified a novel role for leukocyte immunoglobulin-like receptor (LILR) molecules which act to promote neuronal regeneration. This has the potential to treat a wide range of neurodegenerative diseases

Key Benefits

  • Naturally-occurring molecules to use as therapeutic intervention
  • Demonstrated efficacy in vitro

Applications

  • Multiple Sclerosis
  • Alzheimer's Disease
  • Parkinson's Disease
  • Amyotrophic Lateral Sclerosis
  • Motor Neuron Disease
  • Muscular Dystrophy
  • Huntington's Disease
  • Spinal cord regeneration

The Opportunity

UNSW Innovations has recently filed an Australian provisional patent around the technology and is actively seeking development and/or exclusive licensing partners.